MPS Penang & MCPG Northern Engage in Dialogue with Penang Pharmacy Enforcement Division
- Chanwei T
- Feb 19, 2025
- 3 min read
Updated: Feb 24, 2025
๐ Date: 18 February 2025
๐ Venue: Penang Pharmacy Enforcement Division

The Malaysian Pharmacists Society (MPS) Penangย and the Malaysian Community Pharmacy Guild (MCPG) Northern Regionย recently participated in a dialogue sessionย hosted by the Penang Pharmacy Enforcement Division. The session served as a platform for discussion on key issues affecting the pharmacy profession and enforcement matters.
Updates from the Pharmacy Enforcement Division
The session began with an update from the Pharmacy Enforcement Division, presenting the latest statistics and results of enforcement activitiesย conducted across the state. This provided insights into regulatory actions taken against illegal practices, ensuring compliance within the pharmaceutical sector.
Key Concerns Raised by the floor
During the dialogue, MPS Penang Chairman, Mr. Tan Chee Pone, voiced several pressing concerns:
โ Career Progression in the Government Sectorย โ Addressing the limited career advancement opportunitiesย for pharmacists in the public sector, highlighting the need for clearer pathways.
โ Work Stress and Prescription Issuesย โ Emphasizing the immense pressure faced by frontline pharmacists, particularly when handling prescription discrepancies and ensuring regulatory requirement.
โ Online Sales of Health Products & Counterfeit Medicinesย โ Urging stricter monitoring and enforcementย against unauthorized online sales that compromise public health.
โ Clarification on the Medicines (Advertisement & Sale) Act 1956ย โ Seeking guidance on the regulations regarding health-related advertisements, including what can or cannot be displayed in pharmacy settings and online platforms.

MCPG Northern Chairman, Dr. Tan Boon Seng, also raised critical industry concerns, including:
๐น Amendments to Poisons Act (Group B & C Drugs)ย โ He questioned the classification of certain medications, citing Celecoxib as example, given its superior safety profile regarding cardiovascular risk and gastrointestinal bleedingย compared to other NSAIDs, it remains as a Poison B till date.
๐น E-Prescription Platforms & Recognition by MOHย โ With multiple service providers claiming MOH recognition, community pharmacists are unclear on which platforms are officially approved. He urged for an official list from the Pharmaceutical Services Divisionย to ensure compliance and proper verification.
๐นMCPG alsoย raised concerns about the disposal of expired medications. Enforcement authorities clarified that expired medications must be managed by an agency approved by the Department of Environment (JAS) and licensed to handle SW404-classified pharmaceutical waste. MCPG also suggested exploring a collaborative disposal approachย among pharmacies to reduce individual costs. However, as this involves logistical and financial considerations, it will require further discussion among stakeholders rather than direct enforcement involvement.

Clarifications from the Pharmacy Enforcement Division
The Enforcement Division provided key clarifications on the issues raised:
๐ธ Counterfeit Medicinesย โ The division will study the possibility of circulating a list of detected counterfeit medicinesย among community pharmacies to enhance awareness and vigilance.
๐ธ Medicines (Advertisement & Sale) Act 1956ย โ The Head of Advertisement Controlย shared details on the criteria considered when screening advertisement applications, ensuring compliance with regulations.
๐ธ Reclassification of Poisonsย โ The enforcement team emphasized that reclassification efforts require a nationwide initiative from pharmacists, supported by the latest clinical reportsย to advocate for amendments.
๐ธ E-Prescription Certificationย โ Pharmacists can refer to the official list of Certification Authorities and Recognized Platformsย at MCMCย for verification.
๐ธ Safety Alert of Counterfeit Medication - Enforcement Office will facilitate a connection between MCPG Northern, MPS Penang, and NPRAย to ensure pharmacists receive timely alerts on counterfeit medications. This initiative aims to enhance awareness and keep pharmacy professionals informed about potential risks in the supply chain.
Strengthening Collaboration for a Better Future
The dialogue session was attended by Timbalan Pengarah Kesihatan Negeri(Farmasi), Pn. Noraini Binti Ab Kadir, who acknowledged the issues raised and emphasized the need for enhanced communication channelsย between the Enforcement Division, MPS Penang, and MCPG Northern.
Moving forward, all parties agreed to establish direct communication mechanismsย to:
๐ Strengthen collaboration between community pharmacists and enforcement authorities
๐ Facilitate continuous engagement to address industry challenges
This constructive dialogueย marks a significant step in bridging gaps between pharmacists and regulatory bodies, ensuring a safer and more efficient pharmacy landscape in Malaysia.
๐ข Stay tuned for further updates as we work towards a stronger pharmacy profession together!
.png)


